Clinical effects of exogenous/endogenous TNF therapy on metastatic lesions of 34 colorectal cancer patients

Anticancer Research

Volumn 18, Issue 5 D, 1998, Pages 3937-3939

  Tomita, Akira ^a   Fuchino, Yasuhide ^a   Otsuka, Kichiro ^a   Shinohara, Tsurayuki ^a   Tanaka, Shin Nosuke ^a   Umeno, Toshimi ^b   Ikeda, Seiyo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Shinei Hospital   (Japan)

Author keywords

Chemotherapy; EET therapy; Metastatic lesion of colorectal cancer; OK432; TNF

Indexed keywords

FLUOROURACIL; MITOMYCIN C; PICIBANIL; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR;

ADULT; AGED; CANCER INHIBITION; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; FEVER; HUMAN; HYPERTENSION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LUNG METASTASIS; MALE; PRIORITY JOURNAL; SHIVERING; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031743688     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Old LJ: Tumor necrosis factor: Polypeptide mediator network. Nature 326(26): 330-331, 1987.
2. Carswall EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666-70, 1975.
3. Soma G-I, Tuji Y, Kitahara N, Oshima H, Gatabnaga T, Inagawa H, Kato M, Takagi K, Dobashi K, Noguchi K, Tanabe Y, MIzuno D: Novel recombinant TNF molecule (TNF-S) having broad cytotoxic spectra various cancer cells by alteration of amino acids sequence in its N-terminal region. Immunobiology 175: 34-8, 1987.
4. Soma G-I, Tsuji Y, Tanabe Y, Noguchi K, Kitahara-Tanabe N, Gatanaga T, Inagawa H, Kawakami M, Mizuno D: Biological activity of novel recombinant tumor necrosis factor having N-terminal amino acid sequences derived from cytotoxic factors produced by THP-1 cells. J Biol Response Mod 7: 587-95, 1988.
5. Inagawa H, Oshima H, Soma G-I, et al: TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF. J Biol Resp Mod 7: 596-607, 1988.
6. Mizuno D-I, Soma G-I: Endogenous and Exogenous TNF Therapy (EET therapy): Conceptual and experimental grounds. Ann Inst Paster / Immunol 39: 282, 1988.
7. Soma G-I, Mizuno D-I: Exogenous and endogenous tumor necrosis factor therapy. Cancer Surv 8: 837-52, 1989.
8. Dobashi K, Hirata S, Takeshita S, et al: Anti-tumor therapy by induction of endogenous tumor necrosis factor using r-IFN as a priming agent. Biotherapy 1: 133-6, 1987.
9. Gatanaga T, Noguchi K, Tanabe Y, et al: Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-α in vivo. J Biol Resp Mod 8: 278-86, 1989.
10. Satoh M, Oshima H, Abe S, Yamazaki M, Mizuno D-I: Role of in vivo scavenger function of macrophages in priming for endogenous production of tumor necrosis factor. J Biol Resp Mod 6: 499-511, 1987.
11. Satoh M, Inagawa H, Shimada Y, et al: Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferon and other cytokines combined with biological response modifiers of bacterial origin. J Biol Resp Mod 10: 512-24, 1987.
12. Osima, H, Soma, G and Mizuno D: Tumor necrosis factor(TNF): Application of endogenous production for human cancer therapy and its future. Biotherapy 1(2): 145-151, 1987.
13. Tomita A, Umeno T, Fukamura T et al: A case report of a new effective immunological therapy against metastatic lesions from coloncarcmoma. Biotherapy 3(6): 1661-1664, 1989.
14. Tanaka Y, Eda H, Tanaka T, Udagawa T, Horii I, Ishituka H, Kataoka T, Taguchi T: Experimantal cancer cachexia Induced by Transplantable colon 26 adenocarcinoma in mice. Cancer Res 50: 2290-2295, 1990.
15. Tanaka Y, Eda H, Fujimoto K, Tanaka T, Ishikawa T, Ishituka H: Anticachectic activity of 5'-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma. Cancer Res 50: 4528-4532, 1990.